US stocks edged lower on Thursday as Nvidia’s CEO Jensen Huang departure announcement triggered a sell-off in technology shares, raising fresh concerns about the AI investment boom. 

As of 11:00 AM ET, the S&P 500 fell 0.09%, the Nasdaq Composite declined 0.36%, while the Dow Jones gained 0.11%. Nvidia shares tumbled 7%, weighing on chip stocks and broader market sentiment. 

Meanwhile, Brent crude futures surged to around $93 per barrel amid renewed concerns over the US-Iran conflict. 

Additionally, hotter-than-expected inflation data prompted Wall Street analysts to raise expectations for more aggressive Federal Reserve interest rate hikes.

Top Movers: Under $10 

Ainos Inc (AIMD) is up 271.29% today to trade at the current level of $1.80 after announcing that it has signed a $9 million purchase agreement with ASE Technology Holding Co., Ltd. for 5,000 additional AI Nose systems.

Imunon Inc (IMNN) zoomed 9.01% in today’s trade to $0.78 after reporting third-quarter 2026 financial results.

In current trading, enGene Therapeutics Inc (ENGN) stock is at $2.01 after announcing updated results from the pivotal Cohort 1 of its ongoing, Phase 2 LEGEND trial of detalimogene voraplasmid.

Investcorp Credit Management BDC Inc (ICMB) rose 50.87% in the early hours of today's trading to move at $0.93 after announcing financial results for the quarter ended September 30, 2026.

In the current trading session, Tecogen Inc (TGEN) jumped 33.95% to $2.28 over a previous close of $1.7 after reporting third-quarter 2026 financial results.

Stop searching for trades. Start scanning for them.

Stop scrolling chart after chart and second guessing every entry. That's a method problem. In this FREE class, learn how patented AI processes 1.4 million data points every day and forecasts trend direction days in advance with up to 87.4% proven accuracy, so you could start the day with a short list, not a long search.

Save your free seat and see how experienced traders scan the market in minutes.

Ex-Dividend Stocks

ArcBest Corp (ARCB) is about to trade ex-dividend tomorrow, meaning that investors who buy the stock after tomorrow will not be eligible for the next dividend payment. The company's next dividend payment will be $0.12 per share. It has fixed November 13 as the record date for the same and will pay the actual dividend on November 27. Last year, the company distributed a total of $0.48 to its shareholders. Based on last year's worth of payments, ARCB has a trailing yield of 0.35% on the current stock price of $136.19.

Another stock that is shelling out dividends tomorrow is Cintas Corp (CTAS), having a market capitalization of $90.91B. It will pay a dividend of $0.52 per share, the payment date of which is December 15. Currently, the stock is trading at a trailing dividend yield of 0.82%.

Shares of Honeywell International Inc (HON) will be the talk of the stock market on Friday as the stock will turn ex-dividend. The company's next dividend payment will be $0.7 per share, and in the last 12 months, it paid a total of $4.44 per share. Last year's total dividend payments show that HON has a trailing yield of 1.97% on the current share price of $225.13.

Iradimed Corp (IRMD) is also set to go ex-dividend tomorrow. The next dividend payment from IRMD will amount to $0.2 per share. November 13 has been designated as the record date for this dividend, with the actual payout scheduled for November 27. In the previous year, IRMD distributed a total of $0.77 to its valued shareholders. Considering the cumulative dividend payments from last year, the trailing yield for IRMD stands at 0.89% based on the current stock price of $86.58.

Starbucks Corp (SBUX) will be paying out a dividend of $0.63 per share to shareholders holding their shares as of the close of the business hours on the record date of November 13. Over the past 12 months, SBUX has paid out a total of $2.48 per share in dividends. Based on the total dividends paid out last year, SBUX boasts an impressive trailing yield of 2.26% on the current share price of $109.67.

Crypto Market Highlights

• Blockchain protocols have lost 57 cents to hackers for every $1 earned onchain since 2017, according to ARK Invest.

• UK-based digital bank Griffin raised $20 million in a Series B round to expand into card issuance and stablecoin services.

• Tron, Tether and Chainalysis launched a task force to combat illicit USDT activity on the Tron blockchain.

• South Korea plans to let crypto exchanges suspend deposits and withdrawals when hacking is suspected.

• MSCI confirmed that Bitcoin treasury firm Strategy will be removed from its global equity indexes.

Most Shorted Stocks

Beam Therapeutics Inc (BEAM) was one of the most shorted stocks as of latest short interest figures, with 29.61% short interest. The days to cover ratio, a measure of how long it would take for all the short positions to be covered based on average trading volume, is 13.69. This represents a change of -160668 shares, which corresponds to a -0.61% decrease in short interest. The total value of the shares held short is estimated to be around $710.24 million. The average daily volume stands at 1.91M shares, and the market capitalization of the company is $2.56B.

The Editas Medicine Inc with the symbol EDIT currently has a short interest of 27.81%. The short interest has changed by 535288 shares. The days to cover ratio stands at 17.6. The estimated value of the shares held short is approximately $103.38 million. On an average day, 2.35M shares are traded, with the company’s market capitalization totaling $341.86M.

For the stock Medical Properties Trust Inc (MPT), the current short interest is at 30.76%. This represents a significant short interest change of -769340 shares, corresponding to a short interest percentage decrease of 0.51%. The days needed to cover the short positions amount to 7.59. The approximate worth of the shares held short is $334.47 million.

With the symbol FMC, the stock currently has a short interest of 31.01%. The short interest change is 7926694 shares, compared with a short interest percentage change of 26.01. It would take approximately 3.8 days to cover all the short positions. The shares short value is estimated to be around $238.10 million. The company boasts an average daily volume of 8.25M shares, contributing to a market capitalization of $749.01M.

The stock OPEN has a current short interest of 29.21%. The short interest percentage has experienced an increase of 0.9% while there was a change of 2043055 shares in short interest. The ratio indicating the time required to cover short positions is 6.97. The calculated worth of the shorted shares amounts to around $410.57 million. Trading activity averages at 36.79M shares per day, while the company’s market capitalization stands at $1.18B.

The trend starts below the waterline. Your charts never show it.

Put two sailors on one deck, a rookie and a 30-year veteran, and both stare at the same water. Neither can see what's moving underneath. One calls it early, one calls it late, but they're both guessing. This dual-patented AI doesn't guess. It's sonar. It reads the intermarket currents under a stock and spots the move before the chart does. Switch on the sonar in this FREE class.

See what's moving under your charts. Save your seat.

Biotech Stocks to Watch

According to our ST Score evaluation, Corcept Therapeutics Inc (CORT) emerges as a high-quality stock in the Biotech industry, attaining an impressive score of 53. The stock's profitability, growth, financial strength, and Piotroski Score are strong. However, its performance are weak. Additionally, it is neutral in terms of stock sentiment, and forecast.

Our ST Score also classifies Protagonist Therapeutics Inc (PTGX) as a high-quality Biotech stock today, presenting a Score of 56. The stock has strong fundamentals in terms of profitability, performance, financial strength, and Piotroski Score. However, it has weak growth. The stock sentiment and forecast are neutral.

Another stock in the category, Argen X SE ADR (ARGX) has the ST Score of 55, which means that the stock carries the potential for higher returns. The stock is strong in profitability, growth, and financial strength. Performance, stock sentiment, Piotroski score, and forecast suggest a neutral outlook.

Palisade Bio Inc (PALI) stock has the ST Score of 59, which implies that the Biotech company has a high probability of beating the market. The stock's strengths lie in its performance, growth, and financial strength. However, it shows a neutral outlook in profitability, stock sentiment, Piotroski Score, and forecast.

Halozyme Therapeutics Inc (HALO) currently has the ST Score of 66, which signifies a huge upward potential. The Biotech stock's strong points are its profitability, performance, growth, and Piotroski Score. The stock's financial strength, stock sentiment, and forecast indicate a neutral outlook.

That's it for today. Thanks for reading. Good luck out there!

Best Regards,

Stocks Telegraph Team